APA (7th ed.) Citation

Grachev, I. D., Meyer, P. M., Becker, G. A., Bronzel, M., Marsteller, D., Pastino, G., . . . Geva, M. (2021). Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: A [18F] fluspidine and [18F] fallypride PET study. European Journal of Nuclear Medicine & Molecular Imaging, 48(4), 1103. https://doi.org/10.1007/s00259-020-05030-3

Chicago Style (17th ed.) Citation

Grachev, Igor D., et al. "Sigma-1 and Dopamine D2/D3 Receptor Occupancy of Pridopidine in Healthy Volunteers and Patients with Huntington Disease: A [18F] Fluspidine and [18F] Fallypride PET Study." European Journal of Nuclear Medicine & Molecular Imaging 48, no. 4 (2021): 1103. https://doi.org/10.1007/s00259-020-05030-3.

MLA (9th ed.) Citation

Grachev, Igor D., et al. "Sigma-1 and Dopamine D2/D3 Receptor Occupancy of Pridopidine in Healthy Volunteers and Patients with Huntington Disease: A [18F] Fluspidine and [18F] Fallypride PET Study." European Journal of Nuclear Medicine & Molecular Imaging, vol. 48, no. 4, 2021, p. 1103, https://doi.org/10.1007/s00259-020-05030-3.